<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:49:40Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10727372" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10727372</identifier>
        <datestamp>2023-12-19</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jah38945" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10727372</article-id>
              <article-id pub-id-type="pmcid">PMC10727372</article-id>
              <article-id pub-id-type="pmc-uid">10727372</article-id>
              <article-id pub-id-type="pmid">37929770</article-id>
              <article-id pub-id-type="pmid">37929770</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.122.029755</article-id>
              <article-id pub-id-type="publisher-id">JAH38945</article-id>
              <article-id pub-id-type="other">JAHA/2023/029755-T</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Exercise Physiology</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of Long‐Term Home Exercise in Participants With Peripheral Artery Disease</article-title>
                <alt-title alt-title-type="right-running-head">Long‐Term Exercise in Peripheral Artery Disease</alt-title>
                <alt-title alt-title-type="left-running-head">Gardner et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah38945-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Gardner</surname>
                    <given-names>Andrew W.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7721-5438</contrib-id>
                  <xref rid="jah38945-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>andrew-gardner@ouhsc.edu</email>
                  </address>
                </contrib>
                <contrib id="jah38945-cr-0002" contrib-type="author">
                  <name>
                    <surname>Montgomery</surname>
                    <given-names>Polly S.</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref rid="jah38945-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38945-cr-0003" contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Ming</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9977-7041</contrib-id>
                  <xref rid="jah38945-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38945-cr-0004" contrib-type="author">
                  <name>
                    <surname>Liang</surname>
                    <given-names>Menglu</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="jah38945-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="jah38945-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <institution>University of Oklahoma Health Sciences Center</institution>
                <city>Oklahoma City</city>
                <named-content content-type="country-part">OK</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38945-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Population and Quantitative Health Sciences, School of Medicine</named-content>
                <institution>Case Western Reserve University</institution>
                <city>Cleveland</city>
                <named-content content-type="country-part">OH</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38945-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Epidemiology and Biostatistics, School of Public Health</named-content>
                <institution>University of Maryland</institution>
                <city>College Park</city>
                <named-content content-type="country-part">MD</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>
Correspondence to: Andrew W. Gardner, PhD, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, Suite 5400, Oklahoma City, OK 73104. Email: <email>andrew-gardner@ouhsc.edu</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>06</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>07</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="190">21</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.v12.21</issue-id>
              <elocation-id>e029755</elocation-id>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>9</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <!--Copyright &#x000a9; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell-->
                <copyright-statement content-type="article-copyright">© 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JAH3-12-e029755.pdf"/>
              <abstract>
                <sec id="jah38945-sec-0001">
                  <title>Background</title>
                  <p>This randomized controlled trial compared long‐term changes in peak walking time (PWT) and exercise time‐to‐minimum calf muscle oxygen saturation (StO<sub>2</sub>) in symptomatic participants with peripheral artery disease following a long‐term home exercise program (HEP), a short‐term supervised exercise therapy (SET) program that transitioned to a long‐term HEP (SET/HEP), and a control intervention.</p>
                </sec>
                <sec id="jah38945-sec-0002">
                  <title>Methods and Results</title>
                  <p>For the first 3 months, HEP and SET/HEP groups performed intermittent walking to mild‐to‐moderate claudication pain, whereas the control group performed light resistance training. For the subsequent 15 months, the HEP group continued their exercise program, the SET/HEP group transitioned from SET to the HEP program, and the control group transitioned to only receive walking advice. PWT increased significantly from baseline to month 18 in the HEP group (408<monospace>±</monospace>279 meters to 814<monospace>±</monospace>393 meters, <italic toggle="no">P</italic>&lt;0.001) and in the SET/HEP group (457<monospace>±</monospace>288 meters to 818<monospace>±</monospace>313 meters, <italic toggle="no">P</italic>&lt;0.001). Exercise time‐to‐minimum calf muscle StO<sub>2</sub> increased significantly from baseline to month 18 in the HEP group (238<monospace>±</monospace>241 seconds to 497<monospace>±</monospace>485 seconds, <italic toggle="no">P</italic>&lt;0.05) and in the SET/HEP group (296<monospace>±</monospace>289 seconds to 620<monospace>±</monospace>450 seconds, <italic toggle="no">P</italic>&lt;0.001). These changes in PWT and exercise time‐to‐minimum calf muscle StO<sub>2</sub> were greater than in the control group (<italic toggle="no">P</italic>&lt;0.001 and <italic toggle="no">P</italic>&lt;0.01, respectively). Additionally, the change in exercise time‐to‐minimum calf muscle StO<sub>2</sub> was correlated with the change in PWT in both exercise groups combined (<italic toggle="no">r</italic>=0.601, <italic toggle="no">P</italic>=0.0015).</p>
                </sec>
                <sec id="jah38945-sec-0003">
                  <title>Conclusions</title>
                  <p>Long‐term HEP and SET/HEP were efficacious in improving PWT and exercise time‐to‐minimum calf muscle StO<sub>2</sub> in symptomatic participants with peripheral artery disease, and these changes were correlated with each other.</p>
                </sec>
                <sec id="jah38945-sec-0004">
                  <title>Registration</title>
                  <p>URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>; Unique identifier: NCT00618670.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah38945-kwd-0001">claudication</kwd>
                <kwd id="jah38945-kwd-0002">exercise</kwd>
                <kwd id="jah38945-kwd-0003">peripheral vascular disease</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Peripheral Vascular Disease</kwd>
                <kwd>Exercise</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute on Aging
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000049</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01‐AG‐24296</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>Oklahoma Center for Advancement of Science and Technology</funding-source>
                  <award-id>HR09‐035</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>American Heart Association
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000968</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>15GRNT23040034</award-id>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>University of Oklahoma Health Sciences Center General Clinical Research Center</funding-source>
                  <award-id>M01‐RR‐14467</award-id>
                </award-group>
                <award-group id="funding-0005">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Center for Research Resources
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000097</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="5"/>
                <page-count count="13"/>
                <word-count count="6976"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>07 November 2023</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.5 mode:remove_FC converted:20.11.2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="jah38945-ntgp-0001">
                <fn id="jah38945-note-0001">
                  <p>This article was sent to Daniel Edmundowicz, MD, Guest Editor, for review by expert referees, editorial decision, and final disposition.</p>
                </fn>
                <fn id="jah38945-note-0002">
                  <p>For Sources of Funding and Disclosures, see page 11.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jah38945-body-0001">
            <def-list list-content="abbreviations" id="jah38945-lp-0001">
              <title><styled-content style="fixed-case" toggle="no">Nonstandard</styled-content> Abbreviations and Acronyms</title>
              <def-item>
                <term id="jah38945-li-0001">COT</term>
                <def id="jah38945-li-0003">
                  <p>claudication onset time</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38945-li-0004">HEP</term>
                <def id="jah38945-li-0006">
                  <p>home exercise program</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38945-li-0007">MCID</term>
                <def id="jah38945-li-0009">
                  <p>minimal clinically important difference</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38945-li-0010">PWT</term>
                <def id="jah38945-li-0012">
                  <p>peak walking time</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38945-li-0013">SET</term>
                <def id="jah38945-li-0015">
                  <p>supervised exercise therapy</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38945-li-0016">SET/HEP</term>
                <def id="jah38945-li-0017">
                  <p>short‐term supervised exercise therapy program that transitioned to a long‐term home exercise program</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38945-li-0018">StO<sub>2</sub>
</term>
                <def id="jah38945-li-0019">
                  <p>oxygen saturation</p>
                </def>
              </def-item>
            </def-list>
            <p>
              <boxed-text position="anchor" content-type="box" id="jah38945-blkfxd-0001">
                <caption>
                  <title>Clinical Perspective</title>
                </caption>
                <sec id="jah38945-sec-0007">
                  <title>What Is New?</title>
                  <p>
                    <list list-type="bullet" id="jah38945-list-0001">
                      <list-item id="jah38945-li-0020">
                        <p>In symptomatic participants with peripheral artery disease, structured long‐term home exercise was performed with low attrition and high adherence, and was efficacious in improving peak walking time and calf muscle oxygen saturation.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
                <sec id="jah38945-sec-0008">
                  <title>What Are the Clinical Implications?</title>
                  <p>
                    <list list-type="bullet" id="jah38945-list-0002">
                      <list-item id="jah38945-li-0021">
                        <p>Structured long‐term home exercise is a feasible intervention to improve both claudication and microvascular function of the calf muscle in symptomatic participants with peripheral artery disease.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </boxed-text>
            </p>
            <p>Peripheral artery disease (PAD) is highly prevalent worldwide affecting &gt;237 million people.<xref rid="jah38945-bib-0001" ref-type="bibr"><sup>1</sup></xref> A common symptom of PAD is claudication,<xref rid="jah38945-bib-0002" ref-type="bibr"><sup>2</sup></xref> which impairs walking,<xref rid="jah38945-bib-0003" ref-type="bibr"><sup>3</sup></xref> physical function,<xref rid="jah38945-bib-0004" ref-type="bibr"><sup>4</sup></xref> physical activity,<xref rid="jah38945-bib-0005" ref-type="bibr"><sup>5</sup></xref> and health‐related quality of life.<xref rid="jah38945-bib-0006" ref-type="bibr"><sup>6</sup></xref>
</p>
            <p>Supervised exercise therapy (SET) is a class IA recommendation for the treatment of symptomatic PAD.<xref rid="jah38945-bib-0007" ref-type="bibr"><sup>7</sup></xref> However, SET is underused because of several limitations that include being rarely prescribed by clinicians,<xref rid="jah38945-bib-0008" ref-type="bibr"><sup>8</sup></xref> patients having little time and great travel difficulties to exercise facilities,<xref rid="jah38945-bib-0009" ref-type="bibr"><sup>9</sup></xref> having relatively few programs available,<xref rid="jah38945-bib-0010" ref-type="bibr"><sup>10</sup></xref> and nearly 70% of eligible patients are either not interested in participating or report that SET is too inconvenient.<xref rid="jah38945-bib-0011" ref-type="bibr"><sup>11</sup></xref>, <xref rid="jah38945-bib-0012" ref-type="bibr"><sup>12</sup></xref> Of the relatively few patients who enroll in SET, 25% of patients drop out primarily due to their own decision to withdraw.<xref rid="jah38945-bib-0011" ref-type="bibr"><sup>11</sup></xref> Given that the Centers for Medicare and Medicaid Services provides coverage for SET to patients with PAD, which includes 36 sessions during a 12‐week period, with an additional 36 sessions covered throughout their lifetime,<xref rid="jah38945-bib-0013" ref-type="bibr"><sup>13</sup></xref>, <xref rid="jah38945-bib-0014" ref-type="bibr"><sup>14</sup></xref> SET is by its nature a highly efficacious but short‐term experience for patients. Few SET programs have evaluated the long‐term efficacy, and the challenges described for short‐term SET programs become magnified in a long‐term setting.</p>
            <p>To examine a viable alternative to SET, we developed a structured home exercise program (HEP) that used a step activity monitor to provide a similar exercise prescription to SET with fewer barriers.<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> We previously found HEP to be efficacious in these 2 short‐term trials,<xref rid="jah38945-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jah38945-bib-0018" ref-type="bibr"><sup>18</sup></xref> and a recent meta‐analysis supports the efficacy of HEP,<xref rid="jah38945-bib-0017" ref-type="bibr"><sup>17</sup></xref> particularly if objective activity monitoring devices were used.<xref rid="jah38945-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jah38945-bib-0019" ref-type="bibr"><sup>19</sup></xref> Although HEPs may be similar<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref> or inferior<xref rid="jah38945-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jah38945-bib-0020" ref-type="bibr"><sup>20</sup></xref> to SET programs in increasing peak walking time (PWT) in the short‐term, they can elicit walking improvements that are clinically meaningful.<xref rid="jah38945-bib-0021" ref-type="bibr"><sup>21</sup></xref> Furthermore, HEPs offer some potential advantages in a long‐term setting, which is part of the rationale for the strategy to transition patients with PAD from a short‐term SET to a long‐term HEP.<xref rid="jah38945-bib-0014" ref-type="bibr"><sup>14</sup></xref> Limited data are available on the long‐term effects of a structured, monitored HEP, and on the transition from a SET to a long‐term HEP. Therefore, this study was designed to address these knowledge gaps.</p>
            <p>This prospective, randomized controlled clinical trial compared the long‐term changes in the primary outcome measures of PWT and exercise time to minimum calf muscle oxygen saturation (StO<sub>2</sub>) in symptomatic participants with PAD following a long‐term HEP, a short‐term SET that transitioned to a long‐term HEP, and a control group.</p>
            <sec sec-type="methods" id="jah38945-sec-0009">
              <title>Methods</title>
              <sec sec-type="data-availability" id="jah38945-sec-0010">
                <title>Data Availability</title>
                <p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p>
              </sec>
              <sec id="jah38945-sec-0011">
                <title>Participants</title>
                <sec id="jah38945-sec-0012">
                  <title>Approval and Informed Consent</title>
                  <p>The institutional review board at the University of Oklahoma Health Sciences Center and the Research and Development Committee at the Oklahoma City Veterans Affairs Medical Center approved the procedures of this study. Written informed consent was obtained from each participant at the beginning of the investigation.</p>
                </sec>
                <sec id="jah38945-sec-0013">
                  <title>Recruitment</title>
                  <p>Participants underwent baseline evaluations in the study from October 2006 to July 2012. Participants were recruited from vascular laboratories and vascular clinics from the University of Oklahoma Health Sciences Center and the Oklahoma City Veterans Affairs Medical Center.</p>
                </sec>
              </sec>
              <sec id="jah38945-sec-0014">
                <title>Medical Screening Through History and Physical Examination</title>
                <p>Participants were evaluated in the morning at the Clinical Research Center, at the University of Oklahoma Health Sciences Center. Participants arrived fasted, but were permitted to take their usual medications. To begin the study visit, participants were evaluated with a medical history and physical examination in which demographic information, height, weight, waist circumference, cardiovascular risk factors, comorbid conditions, claudication history, ankle/brachial index (ABI), blood samples, and a list of current medications were obtained.</p>
                <sec id="jah38945-sec-0015">
                  <title>Inclusion and Exclusion Criteria</title>
                  <p>Participants with symptomatic PAD were included in this study if they met the following criteria: (1) a history of ambulatory leg pain, (2) ambulatory leg pain confirmed by treadmill exercise,<xref rid="jah38945-bib-0003" ref-type="bibr"><sup>3</sup></xref> and (3) an ABI ≤0.90<xref rid="jah38945-bib-0002" ref-type="bibr"><sup>2</sup></xref> at rest or ≤0.73 after exercise.<xref rid="jah38945-bib-0022" ref-type="bibr"><sup>22</sup></xref> Participants were excluded for the following conditions: (1) absence of PAD (ABI &gt;0.90 at rest and ABI &gt;0.73 after exercise), (2) noncompressible vessels (ABI ≥1.40), (3) asymptomatic PAD, (4) use of medications indicated for the treatment of claudication (cilostazol or pentoxifylline) initiated within 3 months before investigation, (5) exercise limited by other diseases or conditions, (6) active cancer, (7) end stage renal disease defined as stage 5 chronic kidney disease, (8) abnormal liver function, and (9) failure to complete the baseline run‐in phase within 3 weeks, as described previously.<xref rid="jah38945-bib-0018" ref-type="bibr"><sup>18</sup></xref>
</p>
                </sec>
              </sec>
              <sec id="jah38945-sec-0016">
                <title>Interventions</title>
                <sec id="jah38945-sec-0017">
                  <title><styled-content style="fixed-case" toggle="no">HEP</styled-content> Group</title>
                  <p>We used a step activity monitor (StepWatch3; Orthoinnovations, Oklahoma City, OK) to accurately record the duration and cadence of ambulation during exercise training sessions.<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref> The HEP consisted of 3 months of intermittent walking to mild‐to‐moderate claudication pain at least 3 days per week at a self‐selected pace, as previously described.<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> At the completion of the 3‐month HEP and posttests, participants were offered the opportunity to continue in HEP for an additional 15 months. Participants who agreed then returned their step activity monitor and logbook for a 15‐ to 30‐minute meeting with the research staff at the end of month 6, 9, 12, 15, and 18. Similar to the first 3 months of HEP, data were downloaded from the step activity monitor, results were reviewed, feedback was provided, and strategies were discussed to overcome any potential exercise barriers for the upcoming 3 months of training. Adherence to exercise was confirmed by recording the step data from each exercise session.</p>
                </sec>
                <sec id="jah38945-sec-0018">
                  <title><styled-content style="fixed-case" toggle="no">SET</styled-content>/<styled-content style="fixed-case" toggle="no">HEP</styled-content> Group</title>
                  <p>Exercise sessions in our supervised exercise program were performed while wearing a step activity monitor, as previously described.<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref> The SET program consisted of 3 months of intermittent treadmill walking to mild‐to‐moderate claudication pain 3 days per week, as previously described.<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jah38945-bib-0023" ref-type="bibr"><sup>23</sup></xref> Exercise sessions progressively increased during the program from 15 to 40 minutes.<xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> At the completion of the 3‐month SET and posttests, participants were offered the opportunity to continue exercising by transitioning to HEP for an additional 15 months. Participants who agreed then returned their step activity monitor and logbook for a 15‐ to 30‐minute meeting with the research staff at the end of month 6, 9, 12, 15, and 18. Data were downloaded from the step activity monitor, results were reviewed, feedback was provided, and strategies were discussed to overcome any potential exercise barriers for the upcoming 3 months of training. Adherence to exercise was confirmed by recording the step data from each exercise session.</p>
                </sec>
                <sec id="jah38945-sec-0019">
                  <title>Control Group</title>
                  <p>Attention‐control light resistance training was performed in a supervised program 3 times per week for 3 months, without any walking exercise.<xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> This was done to match attention received by the control and SET groups from research staff during the first 3 months in an attempt to rule out attention as a possible explanation for group differences in change scores of outcome measures. At the completion of 3 months of light resistance training, participants were given walking advice without further supervision and were asked if they would be willing to be contacted in 15 months to repeat the research testing. Participants who agreed were then contacted and scheduled for the 18‐month follow‐up testing.</p>
                </sec>
              </sec>
              <sec id="jah38945-sec-0020">
                <title>Tests and Measurements</title>
                <sec id="jah38945-sec-0021">
                  <title>Graded Maximal Treadmill Test</title>
                  <p>Participants performed a graded treadmill test to determine study eligibility, and then repeated the test on a following visit within 1 week. The primary exercise outcome of PWT and a secondary outcome of claudication onset time (COT) were obtained on the repeat test as previously described.<xref rid="jah38945-bib-0003" ref-type="bibr"><sup>3</sup></xref> Calf muscle StO<sub>2</sub> was continuously measured over the medial gastrocnemius muscle of the more symptomatic leg before and during the treadmill test using continuous‐wave, near‐infrared spectroscopy (InSpectra model 325; Hutchinson Technology, Hutchinson, MN).<xref rid="jah38945-bib-0024" ref-type="bibr"><sup>24</sup></xref> A resting baseline value of calf muscle StO<sub>2</sub> was measured following standing on the treadmill for 2 minutes preceding the exercise test, and the primary vascular outcome of exercise time taken to reach the minimum calf StO<sub>2</sub> value was recorded.<xref rid="jah38945-bib-0024" ref-type="bibr"><sup>24</sup></xref>
</p>
                </sec>
                <sec id="jah38945-sec-0022">
                  <title><styled-content style="fixed-case" toggle="no">Six‐Minute</styled-content> Walk Test</title>
                  <p>Participants performed a 6‐minute walk test, and the pain‐free and total walking distances were recorded, as previously described.<xref rid="jah38945-bib-0025" ref-type="bibr"><sup>25</sup></xref>
</p>
                </sec>
                <sec id="jah38945-sec-0023">
                  <title>Walking Impairment Questionnaire</title>
                  <p>Self‐reported ambulatory ability was obtained using a validated questionnaire for PAD participants that assesses ability to walk at various speeds and distances, and to climb stairs.<xref rid="jah38945-bib-0026" ref-type="bibr"><sup>26</sup></xref>
</p>
                </sec>
                <sec id="jah38945-sec-0024">
                  <title>Medical Outcomes Study <styled-content style="fixed-case" toggle="no">Short‐Form</styled-content> 36</title>
                  <p>The self‐reported physical function subscale of health‐related quality of life was assessed from the Medical Outcomes Study Short‐Form 36 instrument.<xref rid="jah38945-bib-0027" ref-type="bibr"><sup>27</sup></xref>
</p>
                </sec>
                <sec id="jah38945-sec-0025">
                  <title>Physical Activity Monitoring</title>
                  <p>Daily walking was measured using a step activity monitor during 7 consecutive days, as we have previously described.<xref rid="jah38945-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jah38945-bib-0028" ref-type="bibr"><sup>28</sup></xref>, <xref rid="jah38945-bib-0029" ref-type="bibr"><sup>29</sup></xref>, <xref rid="jah38945-bib-0030" ref-type="bibr"><sup>30</sup></xref>, <xref rid="jah38945-bib-0031" ref-type="bibr"><sup>31</sup></xref> The total number of steps taken each day and the number of minutes spent walking each day was quantified. Additionally, the number of steps taken each day and the amount of time spent in moderate intensity activity in the community setting were determined, defined as exceeding a cadence of 60 steps per minute by participants with claudication.<xref rid="jah38945-bib-0005" ref-type="bibr"><sup>5</sup></xref>
</p>
                </sec>
                <sec id="jah38945-sec-0026">
                  <title>Circulating Inflammatory and Vascular Biomarkers</title>
                  <p>Blood samples obtained during the medical screening were sent to the clinical laboratory at the University of Oklahoma Health Sciences Center for the measurement of high‐sensitivity C‐reactive protein. Additionally, samples were assayed for the measurement of serum vascular endothelial growth factor‐A, as previously described.<xref rid="jah38945-bib-0032" ref-type="bibr"><sup>32</sup></xref>
</p>
                </sec>
              </sec>
              <sec id="jah38945-sec-0027">
                <title>Randomization and Minimization of Bias</title>
                <p>At the completion of all tests to assess the baseline primary and secondary outcome measures, each participant was randomized to 1 of the 3 groups described above. Participants were randomized using the Number Cruncher Statistical System random number program with blocking to assure that group sizes never differed by &gt;2 at any time during allocation. To reduce selection bias, the allocation sequence was generated by statistical personnel at the Clinical Research Center, and the randomization sequence was concealed from the investigative team until the moment of assignment. Although it was not possible to blind participants to their group assignment, we minimized performance bias by blinding the group assignment to nurses and physicians in the Clinical Research Center and study personnel who conducted the outcome assessments. Exercise technicians administered the interventions but were blinded to the outcome assessments to reduce detection bias. To minimize reporting bias, all data obtained in this trial as primary and secondary outcome measurements are reported in the tables. To minimize attrition bias, all participants were contacted to schedule research tests at month 3 and month 18 regardless of adherence during the interventions. Finally, all participants received their allocated exercise treatment or control condition.</p>
              </sec>
              <sec id="jah38945-sec-0028">
                <title>Statistical Analysis</title>
                <p>Descriptive statistics were summarized for measurable variables (eg, baseline, demographic, and clinical characteristics, and exercise intervention and performance measures) by groups (control, SET/HEP, HEP) or by time points (baseline, 3 months, 18 months) as means and standard deviations for continuous variables, and frequencies with percentages for categorical variables. For exercise intervention measures, the changes from baseline to 3 months and those from 3 months to 18 months were the metrics used for measuring impact of exercise program. For exercise performance measures, daily ambulatory activity measures, and vascular measures, the changes from baseline at 3 months and 18 months were considered as metrics for comparisons. For continuous measures, the 1‐way ANOVA or Kruskal‐Wallis tests were used for 3‐group comparisons, and 2‐sample <italic toggle="yes">t</italic> tests or Wilcoxon rank sum tests for 2‐group comparisons, as appropriate; for categorical variables, χ<sup>2</sup> tests or Fisher exact tests were adopted for group comparison, as appropriate. Specifically, for the primary and secondary outcomes of interest, we used the Dunnett test to further assess the 2 experimental treatment groups against the control group by incorporating the dependencies between these comparisons. Correlation analysis was performed to assess the association between outcomes by calculating Pearson correlation coefficient with <italic toggle="yes">P</italic> values based on <italic toggle="yes">t</italic> tests to conclude if it was significantly different from 0. Furthermore, we followed the intent‐to‐treat analysis principle for analysis by using mixed‐effects models with random intercepts under the assumption of missing at random. The baseline measures as well as potential confounding variables were adjusted to evaluate overall group comparison. Bonferroni correction was used for the <italic toggle="yes">P</italic> value adjustment of multiple comparisons of multivariate outcomes from each domain. Significance for all analyses was determined using 2‐sided tests with the significance level of 0.05. The data analysis was performed in SAS version 9.4.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jah38945-sec-0029">
              <title>Results</title>
              <sec id="jah38945-sec-0030">
                <title>Baseline Clinical Characteristics and Participant Flow Through the Trial</title>
                <p>Participant flow in the study is shown in Figure <xref rid="jah38945-fig-0001" ref-type="fig">1</xref>. A total of 180 participants were randomized equally into 3 groups, and 156 completed the 3‐month follow‐up consisting of 53 from the HEP group, 52 from the SET group, and 51 from the control group. Eighteen of the 53 participants in the HEP group, 20 of the 52 participants in the SET group, and 34 of the 51 participants in the control group agreed to continue in the long‐term phase of the study. Baseline characteristics of those participating in the long‐term phase of the study were not significantly different among the groups (Table <xref rid="jah38945-tbl-0001" ref-type="table">1</xref>). Sixty‐eight participants completed the 18‐month follow‐up, whereas 4 did not complete it. Missing data in the trial consisted of the missing posttest observations at 18 months from 2 participants in the HEP group and 2 participants in the SET/HEP group who did not complete the long‐term phase of the study based on personal decisions. No participant was discontinued due to serious adverse events, and only 6 unanticipated problems occurred, and none of which interfered with participation in the study.</p>
                <fig position="float" fig-type="Figure" id="jah38945-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <title>Consolidated standards of reporting trials flow diagram of participants through the trial.</title>
                    <p>ITT indicates intent‐to‐treat; and PAD, peripheral artery disease.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e029755-g001" position="anchor" id="jats-graphic-1"/>
                </fig>
                <table-wrap position="float" id="jah38945-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline Clinical Characteristics</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variables</th>
                        <th align="left" rowspan="1" colspan="1">Control group (n=34)</th>
                        <th align="left" rowspan="1" colspan="1">SET/HEP group (n=20)</th>
                        <th align="left" rowspan="1" colspan="1">HEP group (n=18)</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, y</td>
                        <td align="left" rowspan="1" colspan="1">66±9</td>
                        <td align="left" rowspan="1" colspan="1">65±9</td>
                        <td align="left" rowspan="1" colspan="1">64±11</td>
                        <td align="left" rowspan="1" colspan="1">0.763</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Weight, kg</td>
                        <td align="left" rowspan="1" colspan="1">87.9±19.1</td>
                        <td align="left" rowspan="1" colspan="1">82.8±10.5</td>
                        <td align="left" rowspan="1" colspan="1">77.1±14.3</td>
                        <td align="left" rowspan="1" colspan="1">0.244</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">31.1±6.1</td>
                        <td align="left" rowspan="1" colspan="1">29.8±4.8</td>
                        <td align="left" rowspan="1" colspan="1">27.1±5.0</td>
                        <td align="left" rowspan="1" colspan="1">0.107</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Ankle/brachial index</td>
                        <td align="left" rowspan="1" colspan="1">0.68±0.25</td>
                        <td align="left" rowspan="1" colspan="1">0.67±0.24</td>
                        <td align="left" rowspan="1" colspan="1">0.73±0.16</td>
                        <td align="left" rowspan="1" colspan="1">0.645</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sex, men</td>
                        <td align="left" rowspan="1" colspan="1">15 (44)</td>
                        <td align="left" rowspan="1" colspan="1">10 (50)</td>
                        <td align="left" rowspan="1" colspan="1">9 (50)</td>
                        <td align="left" rowspan="1" colspan="1">0.866</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Race, White</td>
                        <td align="left" rowspan="1" colspan="1">13 (38)</td>
                        <td align="left" rowspan="1" colspan="1">7 (35)</td>
                        <td align="left" rowspan="1" colspan="1">7 (39)</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Current smoking</td>
                        <td align="left" rowspan="1" colspan="1">8 (24)</td>
                        <td align="left" rowspan="1" colspan="1">9 (45)</td>
                        <td align="left" rowspan="1" colspan="1">7 (39)</td>
                        <td align="left" rowspan="1" colspan="1">0.236</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Hypertension</td>
                        <td align="left" rowspan="1" colspan="1">29 (85)</td>
                        <td align="left" rowspan="1" colspan="1">19 (95)</td>
                        <td align="left" rowspan="1" colspan="1">17 (94)</td>
                        <td align="left" rowspan="1" colspan="1">0.595</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Dyslipidemia</td>
                        <td align="left" rowspan="1" colspan="1">32 (94)</td>
                        <td align="left" rowspan="1" colspan="1">18 (90)</td>
                        <td align="left" rowspan="1" colspan="1">15 (83)</td>
                        <td align="left" rowspan="1" colspan="1">0.394</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Diabetes</td>
                        <td align="left" rowspan="1" colspan="1">19 (56)</td>
                        <td align="left" rowspan="1" colspan="1">11 (55)</td>
                        <td align="left" rowspan="1" colspan="1">7 (39)</td>
                        <td align="left" rowspan="1" colspan="1">0.491</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Abdominal obesity</td>
                        <td align="left" rowspan="1" colspan="1">20 (59)</td>
                        <td align="left" rowspan="1" colspan="1">11 (55)</td>
                        <td align="left" rowspan="1" colspan="1">5 (28)</td>
                        <td align="left" rowspan="1" colspan="1">0.104</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Metabolic syndrome</td>
                        <td align="left" rowspan="1" colspan="1">29 (85)</td>
                        <td align="left" rowspan="1" colspan="1">18 (90)</td>
                        <td align="left" rowspan="1" colspan="1">14 (78)</td>
                        <td align="left" rowspan="1" colspan="1">0.639</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Obesity</td>
                        <td align="left" rowspan="1" colspan="1">18 (53)</td>
                        <td align="left" rowspan="1" colspan="1">9 (45)</td>
                        <td align="left" rowspan="1" colspan="1">6 (33)</td>
                        <td align="left" rowspan="1" colspan="1">0.401</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Lower extremity revascularization</td>
                        <td align="left" rowspan="1" colspan="1">12 (35)</td>
                        <td align="left" rowspan="1" colspan="1">10 (50)</td>
                        <td align="left" rowspan="1" colspan="1">10 (56)</td>
                        <td align="left" rowspan="1" colspan="1">0.344</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Coronary artery disease</td>
                        <td align="left" rowspan="1" colspan="1">12 (35)</td>
                        <td align="left" rowspan="1" colspan="1">9 (45)</td>
                        <td align="left" rowspan="1" colspan="1">7 (39)</td>
                        <td align="left" rowspan="1" colspan="1">0.781</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Myocardial infarction</td>
                        <td align="left" rowspan="1" colspan="1">5 (15)</td>
                        <td align="left" rowspan="1" colspan="1">7 (35)</td>
                        <td align="left" rowspan="1" colspan="1">3 (17)</td>
                        <td align="left" rowspan="1" colspan="1">0.216</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Cerebrovascular disease</td>
                        <td align="left" rowspan="1" colspan="1">4 (12)</td>
                        <td align="left" rowspan="1" colspan="1">6 (30)</td>
                        <td align="left" rowspan="1" colspan="1">3 (17)</td>
                        <td align="left" rowspan="1" colspan="1">0.235</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Chronic kidney disease</td>
                        <td align="left" rowspan="1" colspan="1">12 (35)</td>
                        <td align="left" rowspan="1" colspan="1">2 (10)</td>
                        <td align="left" rowspan="1" colspan="1">4 (22)</td>
                        <td align="left" rowspan="1" colspan="1">0.119</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td>
                        <td align="left" rowspan="1" colspan="1">8 (24)</td>
                        <td align="left" rowspan="1" colspan="1">5 (25)</td>
                        <td align="left" rowspan="1" colspan="1">3 (17)</td>
                        <td align="left" rowspan="1" colspan="1">0.873</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Dyspnea</td>
                        <td align="left" rowspan="1" colspan="1">16 (47)</td>
                        <td align="left" rowspan="1" colspan="1">11 (55)</td>
                        <td align="left" rowspan="1" colspan="1">12 (67)</td>
                        <td align="left" rowspan="1" colspan="1">0.401</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Arthritis</td>
                        <td align="left" rowspan="1" colspan="1">19 (56)</td>
                        <td align="left" rowspan="1" colspan="1">11 (55)</td>
                        <td align="left" rowspan="1" colspan="1">9 (50)</td>
                        <td align="left" rowspan="1" colspan="1">0.953</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38945-ntgp-0002">
                    <fn id="jah38945-note-0003">
                      <p>Data are presented as mean±SD or number (percent) of participants with characteristic present. HEP indicates home exercise program; and SET, supervised exercise therapy.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah38945-sec-0031">
                <title>Exercise Intervention Measures</title>
                <p>The SET/HEP group completed more exercise sessions during the 18‐month exercise intervention than the HEP group, which occurred primarily during months 3 and 18 (Table <xref rid="jah38945-tbl-0002" ref-type="table">2</xref>). However, the SET/HEP group walked for an average of 12 fewer minutes per session during the 18‐month intervention, yielding a similar number of steps taken during each session between the 2 exercise groups.</p>
                <table-wrap position="float" id="jah38945-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Long‐Term Exercise Intervention Measures</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variables</th>
                        <th align="left" rowspan="1" colspan="1">SET/HEP group</th>
                        <th align="left" rowspan="1" colspan="1">HEP group</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">0–18 mo</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Exercise sessions completed</td>
                        <td align="left" rowspan="1" colspan="1">237.3±23.1</td>
                        <td align="left" rowspan="1" colspan="1">192.8±46.6</td>
                        <td align="left" rowspan="1" colspan="1">0.011</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average exercise time, min per exercise session</td>
                        <td align="left" rowspan="1" colspan="1">30.6±5.4</td>
                        <td align="left" rowspan="1" colspan="1">42.7±21.5</td>
                        <td align="left" rowspan="1" colspan="1">0.081</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average exercise steps, steps per exercise session</td>
                        <td align="left" rowspan="1" colspan="1">2511±490</td>
                        <td align="left" rowspan="1" colspan="1">3228±1186</td>
                        <td align="left" rowspan="1" colspan="1">0.135</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average exercise cadence, steps per min</td>
                        <td align="left" rowspan="1" colspan="1">82.4±13.6</td>
                        <td align="left" rowspan="1" colspan="1">79.6±15.4</td>
                        <td align="left" rowspan="1" colspan="1">0.569</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">3–18 mo</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Exercise sessions completed</td>
                        <td align="left" rowspan="1" colspan="1">203.7±21.5</td>
                        <td align="left" rowspan="1" colspan="1">158.3±49.0</td>
                        <td align="left" rowspan="1" colspan="1">0.004</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average exercise time, min per exercise session</td>
                        <td align="left" rowspan="1" colspan="1">29.5±5.7</td>
                        <td align="left" rowspan="1" colspan="1">43.8±25.2</td>
                        <td align="left" rowspan="1" colspan="1">0.045</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average exercise steps, steps per exercise session</td>
                        <td align="left" rowspan="1" colspan="1">2402±500</td>
                        <td align="left" rowspan="1" colspan="1">3328±1363</td>
                        <td align="left" rowspan="1" colspan="1">0.088</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average exercise cadence, steps per min</td>
                        <td align="left" rowspan="1" colspan="1">82.2±14.4</td>
                        <td align="left" rowspan="1" colspan="1">80.8±16.8</td>
                        <td align="left" rowspan="1" colspan="1">0.850</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38945-ntgp-0003">
                    <fn id="jah38945-note-0004">
                      <p>Data are presented as mean±SD. HEP indicates home exercise program; and SET, supervised exercise therapy.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah38945-sec-0032">
                <title>Outcome Measures</title>
                <p>The change scores for PWT and COT were different among the 3 groups between baseline and month 18 (Table <xref rid="jah38945-tbl-0003" ref-type="table">3</xref>). The primary exercise outcome of PWT increased significantly in the HEP group (408<monospace>±</monospace>279 seconds to 814<monospace>±</monospace>393 seconds; change=343<monospace>±</monospace>289 seconds; <italic toggle="yes">P</italic>&lt;0.001) and SET/HEP group (457<monospace>±</monospace>288 seconds to 818<monospace>±</monospace>313 seconds; change=336<monospace>±</monospace>245 seconds; <italic toggle="yes">P</italic>&lt;0.001). No significant changes were found in the control group. For the comparison between month 3 and month 18, the change score for PWT was different among the 3 groups, because it increased significantly in the HEP group (580<monospace>±</monospace>381 seconds to 814<monospace>±</monospace>393 seconds; change=234<monospace>±</monospace>227 seconds; <italic toggle="yes">P</italic>&lt;0.001) and SET/HEP group (614<monospace>±</monospace>295 seconds to 818<monospace>±</monospace>313 seconds; change=180<monospace>±</monospace>274 seconds; <italic toggle="yes">P</italic>&lt;0.001), but not in the control group.</p>
                <table-wrap position="float" id="jah38945-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>Long‐Term Exercise Performance Measures</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variables/group</th>
                        <th align="left" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" rowspan="1" colspan="1">3 mo</th>
                        <th align="left" rowspan="1" colspan="1">18 mo</th>
                        <th align="left" rowspan="1" colspan="1">Change score (0–18 mo)</th>
                        <th align="left" rowspan="1" colspan="1">Change score (3–18 mo)</th>
                        <th align="left" rowspan="1" colspan="1">Mixed‐effects model* (0–18 mo), <italic toggle="yes">P</italic> value</th>
                        <th align="left" rowspan="1" colspan="1">Mixed‐effects model* (3–18 mo), <italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Peak walking time, s</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">446±270</td>
                        <td align="left" rowspan="1" colspan="1">468±257</td>
                        <td align="left" rowspan="1" colspan="1">487±290</td>
                        <td align="left" rowspan="1" colspan="1">41±166</td>
                        <td align="left" rowspan="1" colspan="1">19±160</td>
                        <td align="left" rowspan="3" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="3" colspan="1">0.003</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">457±288</td>
                        <td align="left" rowspan="1" colspan="1">614±295</td>
                        <td align="left" rowspan="1" colspan="1">818±313</td>
                        <td align="left" rowspan="1" colspan="1">336±245<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0008" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">180±274<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">408±279</td>
                        <td align="left" rowspan="1" colspan="1">580±381</td>
                        <td align="left" rowspan="1" colspan="1">814±393</td>
                        <td align="left" rowspan="1" colspan="1">367±177<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0008" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">234±227<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0010" ref-type="table-fn">‖</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Claudication onset time, s</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">194±102</td>
                        <td align="left" rowspan="1" colspan="1">266±158</td>
                        <td align="left" rowspan="1" colspan="1">300±205</td>
                        <td align="left" rowspan="1" colspan="1">106±164</td>
                        <td align="left" rowspan="1" colspan="1">34±149</td>
                        <td align="left" rowspan="1" colspan="1">0.007</td>
                        <td align="left" rowspan="1" colspan="1">0.072</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">239±252</td>
                        <td align="left" rowspan="1" colspan="1">382±294</td>
                        <td align="left" rowspan="1" colspan="1">528±298</td>
                        <td align="left" rowspan="1" colspan="1">272±287<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">132±347</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">233±178</td>
                        <td align="left" rowspan="1" colspan="1">360±310</td>
                        <td align="left" rowspan="1" colspan="1">601±374</td>
                        <td align="left" rowspan="1" colspan="1">343±289<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0010" ref-type="table-fn">‖</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">241±313<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>
</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">6‐Minute walk distance, m</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">344±87</td>
                        <td align="left" rowspan="1" colspan="1">347±96</td>
                        <td align="left" rowspan="1" colspan="1">346±86</td>
                        <td align="left" rowspan="1" colspan="1">2±43</td>
                        <td align="left" rowspan="1" colspan="1">−2±55</td>
                        <td align="left" rowspan="3" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="3" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">360±88</td>
                        <td align="left" rowspan="1" colspan="1">383±91</td>
                        <td align="left" rowspan="1" colspan="1">445±71</td>
                        <td align="left" rowspan="1" colspan="1">80±54<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0008" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">59±57<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0008" ref-type="table-fn">‡</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">385±54</td>
                        <td align="left" rowspan="1" colspan="1">402±69</td>
                        <td align="left" rowspan="1" colspan="1">443±84</td>
                        <td align="left" rowspan="1" colspan="1">62±71<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0008" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">40±48<xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>, <xref rid="jah38945-note-0011" ref-type="table-fn">¶</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">MOS SF‐36 PF score, %</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">46±22</td>
                        <td align="left" rowspan="1" colspan="1">45±21</td>
                        <td align="left" rowspan="1" colspan="1">49±23</td>
                        <td align="left" rowspan="1" colspan="1">4±13</td>
                        <td align="left" rowspan="1" colspan="1">5±19</td>
                        <td align="left" rowspan="1" colspan="1">0.230</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">43±22</td>
                        <td align="left" rowspan="1" colspan="1">54±17</td>
                        <td align="left" rowspan="1" colspan="1">57±22</td>
                        <td align="left" rowspan="1" colspan="1">13±23<xref rid="jah38945-note-0012" ref-type="table-fn">#</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">3±18</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">41±22</td>
                        <td align="left" rowspan="1" colspan="1">57±21</td>
                        <td align="left" rowspan="1" colspan="1">57±22</td>
                        <td align="left" rowspan="1" colspan="1">15±12<xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>, <xref rid="jah38945-note-0012" ref-type="table-fn">#</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0±17</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">WIQ distance score, %</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">35±26</td>
                        <td align="left" rowspan="1" colspan="1">30±24</td>
                        <td align="left" rowspan="1" colspan="1">40±29</td>
                        <td align="left" rowspan="1" colspan="1">5±21</td>
                        <td align="left" rowspan="1" colspan="1">7±20</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">44±39</td>
                        <td align="left" rowspan="1" colspan="1">42±29</td>
                        <td align="left" rowspan="1" colspan="1">60±33</td>
                        <td align="left" rowspan="1" colspan="1">13±38</td>
                        <td align="left" rowspan="1" colspan="1">15±30</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">33±33</td>
                        <td align="left" rowspan="1" colspan="1">51±36</td>
                        <td align="left" rowspan="1" colspan="1">54±35</td>
                        <td align="left" rowspan="1" colspan="1">19±31<xref rid="jah38945-note-0011" ref-type="table-fn">¶</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">3±26</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">WIQ speed score, %</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">37±23</td>
                        <td align="left" rowspan="1" colspan="1">32±18</td>
                        <td align="left" rowspan="1" colspan="1">37±24</td>
                        <td align="left" rowspan="1" colspan="1">1±21</td>
                        <td align="left" rowspan="1" colspan="1">4±18</td>
                        <td align="left" rowspan="1" colspan="1">0.007</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">32±28</td>
                        <td align="left" rowspan="1" colspan="1">42±24</td>
                        <td align="left" rowspan="1" colspan="1">51±24</td>
                        <td align="left" rowspan="1" colspan="1">16±25<xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>, <xref rid="jah38945-note-0012" ref-type="table-fn">#</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">7±24</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">32±27</td>
                        <td align="left" rowspan="1" colspan="1">46±28</td>
                        <td align="left" rowspan="1" colspan="1">54±26</td>
                        <td align="left" rowspan="1" colspan="1">21±22<xref rid="jah38945-note-0007" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0009" ref-type="table-fn">§</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">8±18</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">WIQ stair climbing score, %</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">41±31</td>
                        <td align="left" rowspan="1" colspan="1">35±27</td>
                        <td align="left" rowspan="1" colspan="1">38±32</td>
                        <td align="left" rowspan="1" colspan="1">−1±24</td>
                        <td align="left" rowspan="1" colspan="1">2±24</td>
                        <td align="left" rowspan="1" colspan="1">0.051</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">44±31</td>
                        <td align="left" rowspan="1" colspan="1">49±32</td>
                        <td align="left" rowspan="1" colspan="1">55±32</td>
                        <td align="left" rowspan="1" colspan="1">10±32</td>
                        <td align="left" rowspan="1" colspan="1">3±34</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">35±26</td>
                        <td align="left" rowspan="1" colspan="1">43±26</td>
                        <td align="left" rowspan="1" colspan="1">56±23</td>
                        <td align="left" rowspan="1" colspan="1">22±19<xref rid="jah38945-note-0010" ref-type="table-fn">‖</xref>, <xref rid="jah38945-note-0012" ref-type="table-fn">#</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">14±19</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38945-ntgp-0004">
                    <fn id="jah38945-note-0005">
                      <p>Data are presented as mean±SD. HEP indicates home exercise program; MOS SF‐36 PF, Medical Outcomes Study Short Form‐36 Physical Function; SET, supervised exercise therapy; and WIQ, Walking Impairment Questionnaire.</p>
                    </fn>
                    <fn id="jah38945-note-0006">
                      <label>*</label>
                      <p>The models consider the variables of baseline outcome measures, group, visit time, and interaction between group and visit time. The <italic toggle="yes">P</italic> values are from type III <italic toggle="yes">F</italic> test sums of squares and were adjusted using the Bonferroni correction method.</p>
                    </fn>
                    <fn id="jah38945-note-0007">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.001.</p>
                    </fn>
                    <fn id="jah38945-note-0008">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.001.</p>
                    </fn>
                    <fn id="jah38945-note-0009">
                      <label>
                        <sup>§</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.05.</p>
                    </fn>
                    <fn id="jah38945-note-0010">
                      <label>
                        <sup>‖</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.01.</p>
                    </fn>
                    <fn id="jah38945-note-0011">
                      <label>
                        <sup>¶</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.05.</p>
                    </fn>
                    <fn id="jah38945-note-0012">
                      <label>
                        <sup>#</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.01.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The change scores for 6‐minute walk distance and Walking Impairment Questionnaire speed score were different among the 3 groups between baseline and month 18 (Table <xref rid="jah38945-tbl-0003" ref-type="table">3</xref>). Both outcome measures increased significantly in the HEP and SET/HEP groups. No significant changes were found in the control group. For the comparison between month 3 and month 18, the change score for 6‐minute walk distance was different among the 3 groups, because it increased significantly in the HEP and SET/HEP groups, but not in the control group.</p>
                <p>The change scores for steps at moderate intensity and time spent in moderate intensity activity were different among the 3 groups between baseline and month 18 (Table <xref rid="jah38945-tbl-0004" ref-type="table">4</xref>). Both outcome measures increased significantly in the HEP and SET/HEP groups, but not in the control group. For the comparison between month 3 and month 18, none of the change scores were significantly different among the 3 groups.</p>
                <table-wrap position="float" id="jah38945-tbl-0004" content-type="Table">
                  <label>Table 4</label>
                  <caption>
                    <p>Long‐Term Daily Ambulatory Activity Measures</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variables/groups</th>
                        <th align="left" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" rowspan="1" colspan="1">3 mo</th>
                        <th align="left" rowspan="1" colspan="1">18 mo</th>
                        <th align="left" rowspan="1" colspan="1">Change score (0–18 mo)</th>
                        <th align="left" rowspan="1" colspan="1">Change score (3–18 mo)</th>
                        <th align="left" rowspan="1" colspan="1">Mixed‐effects model<xref rid="jah38945-note-0014" ref-type="table-fn">*</xref> (0–18 mo), <italic toggle="yes">P</italic> value</th>
                        <th align="left" rowspan="1" colspan="1">Mixed‐effects model<xref rid="jah38945-note-0007" ref-type="table-fn">*</xref> (3–18 mo), <italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Total daily steps, steps per d</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">6163±3349</td>
                        <td align="left" rowspan="1" colspan="1">5999±2838</td>
                        <td align="left" rowspan="1" colspan="1">6303±3006</td>
                        <td align="left" rowspan="1" colspan="1">228±2221</td>
                        <td align="left" rowspan="1" colspan="1">304±1870</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">7116±3458</td>
                        <td align="left" rowspan="1" colspan="1">7927±3042</td>
                        <td align="left" rowspan="1" colspan="1">8116±3821</td>
                        <td align="left" rowspan="1" colspan="1">491±1739</td>
                        <td align="left" rowspan="1" colspan="1">189±1890</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">6993±2431</td>
                        <td align="left" rowspan="1" colspan="1">6252±2840</td>
                        <td align="left" rowspan="1" colspan="1">7486±2390</td>
                        <td align="left" rowspan="1" colspan="1">333±2457</td>
                        <td align="left" rowspan="1" colspan="1">1160±2935</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Total activity time, min/d</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">241±105</td>
                        <td align="left" rowspan="1" colspan="1">242±93</td>
                        <td align="left" rowspan="1" colspan="1">254±97</td>
                        <td align="left" rowspan="1" colspan="1">13±80</td>
                        <td align="left" rowspan="1" colspan="1">12±65</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                        <td align="left" rowspan="1" colspan="1">0.337</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">282±95</td>
                        <td align="left" rowspan="1" colspan="1">310±72</td>
                        <td align="left" rowspan="1" colspan="1">291±86</td>
                        <td align="left" rowspan="1" colspan="1">−8±51</td>
                        <td align="left" rowspan="1" colspan="1">−19±56</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">311±102</td>
                        <td align="left" rowspan="1" colspan="1">271±101</td>
                        <td align="left" rowspan="1" colspan="1">318±109</td>
                        <td align="left" rowspan="1" colspan="1">−1±100</td>
                        <td align="left" rowspan="1" colspan="1">45±121</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Steps at moderate intensity, steps per d</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">1541±1534</td>
                        <td align="left" rowspan="1" colspan="1">1390±1279</td>
                        <td align="left" rowspan="1" colspan="1">1455±1283</td>
                        <td align="left" rowspan="1" colspan="1">22±887</td>
                        <td align="left" rowspan="1" colspan="1">65±1056</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.155</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">1675±1763</td>
                        <td align="left" rowspan="1" colspan="1">3474±1620</td>
                        <td align="left" rowspan="1" colspan="1">2857±1749</td>
                        <td align="left" rowspan="1" colspan="1">1019±493<xref rid="jah38945-note-0015" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0016" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">−618±970<xref rid="jah38945-note-0017" ref-type="table-fn">§</xref>
</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">1510±1069</td>
                        <td align="left" rowspan="1" colspan="1">2786±1369</td>
                        <td align="left" rowspan="1" colspan="1">3052±1104</td>
                        <td align="left" rowspan="1" colspan="1">1438±1200<xref rid="jah38945-note-0015" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0016" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">285±923</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Time spent in moderate intensity activity, min/d</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">19±18</td>
                        <td align="left" rowspan="1" colspan="1">17±15</td>
                        <td align="left" rowspan="1" colspan="1">19±16</td>
                        <td align="left" rowspan="1" colspan="1">1±11</td>
                        <td align="left" rowspan="1" colspan="1">1±13</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.176</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">21±21</td>
                        <td align="left" rowspan="1" colspan="1">43±21</td>
                        <td align="left" rowspan="1" colspan="1">36±22</td>
                        <td align="left" rowspan="1" colspan="1">12±7<xref rid="jah38945-note-0015" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0018" ref-type="table-fn">‖</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">−7±13</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">19±11</td>
                        <td align="left" rowspan="1" colspan="1">36±15</td>
                        <td align="left" rowspan="1" colspan="1">39±17</td>
                        <td align="left" rowspan="1" colspan="1">20±17<xref rid="jah38945-note-0015" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0016" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">4±11</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38945-ntgp-0005">
                    <fn id="jah38945-note-0013">
                      <p>Data are presented as mean±SD. HEP indicates home exercise program; and SET, supervised exercise therapy.</p>
                    </fn>
                    <fn id="jah38945-note-0014">
                      <label>*</label>
                      <p>The models consider the variables of baseline outcome measures, group, visit time, and interaction between group and visit time. The <italic toggle="yes">P</italic> values are from type III <italic toggle="yes">F</italic> test sums of squares and were adjusted using the Bonferroni correction method.</p>
                    </fn>
                    <fn id="jah38945-note-0015">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.001.</p>
                    </fn>
                    <fn id="jah38945-note-0016">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.001.</p>
                    </fn>
                    <fn id="jah38945-note-0017">
                      <label>
                        <sup>§</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.05.</p>
                    </fn>
                    <fn id="jah38945-note-0018">
                      <label>
                        <sup>‖</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.01.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The change scores for the primary vascular outcome of time to minimum calf StO<sub>2</sub> was different among the 3 groups between baseline and month 18 (Table <xref rid="jah38945-tbl-0005" ref-type="table">5</xref>). The time to minimum calf StO<sub>2</sub> increased significantly in the HEP group (238<monospace>±</monospace>241 seconds to 497<monospace>±</monospace>485 seconds; change=221<monospace>±</monospace>343 seconds; <italic toggle="yes">P</italic>&lt;0.05) and SET/HEP group (296<monospace>±</monospace>289 seconds to 620<monospace>±</monospace>450 seconds; change=326<monospace>±</monospace>400 seconds; <italic toggle="yes">P</italic>&lt;0.001), but not in the control group. For the comparison between month 3 and month 18, the change score for time to minimum calf StO<sub>2</sub> was different among the 3 groups, because it increased significantly in the SET/HEP group (373<monospace>±</monospace>330 seconds to 620<monospace>±</monospace>450 seconds; change=213<monospace>±</monospace>381 seconds; <italic toggle="yes">P</italic>&lt;0.01), but not in the HEP and control groups. As shown in Figure <xref rid="jah38945-fig-0002" ref-type="fig">2</xref>, when combining both exercise groups, the change in the time to minimum calf StO<sub>2</sub> was moderately correlated with the change in PWT from baseline to month 18 (<italic toggle="yes">r</italic>=0.601, <italic toggle="yes">P</italic>=0.0015), and from month 3 to month 18 (<italic toggle="yes">r</italic>=0.600, <italic toggle="yes">P</italic>=0.0020). These respective correlations were also significant in the SET/HEP group (<italic toggle="yes">r</italic>=0.648, <italic toggle="yes">P</italic>=0.0121 and <italic toggle="yes">r</italic>=0.691, <italic toggle="yes">P</italic>=0.0062).</p>
                <table-wrap position="float" id="jah38945-tbl-0005" content-type="Table">
                  <label>Table 5</label>
                  <caption>
                    <p>Long‐Term Vascular Measures</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variables/groups</th>
                        <th align="left" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" rowspan="1" colspan="1">3 mo</th>
                        <th align="left" rowspan="1" colspan="1">18 mo</th>
                        <th align="left" rowspan="1" colspan="1">Change score (0–18 mo)</th>
                        <th align="left" rowspan="1" colspan="1">Change score (3–18 mo)</th>
                        <th align="left" rowspan="1" colspan="1">Mixed‐effects model<xref rid="jah38945-note-0020" ref-type="table-fn">*</xref> (0–18 mo), <italic toggle="yes">P</italic> value</th>
                        <th align="left" style="border-bottom:solid 1px #000000" rowspan="1" colspan="1">Mixed‐effects model<xref rid="jah38945-note-0020" ref-type="table-fn">*</xref> (3–18 mo), <italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">Time to minimum calf StO<sub>2</sub>, s</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">244±243</td>
                        <td align="left" rowspan="1" colspan="1">247±204</td>
                        <td align="left" rowspan="1" colspan="1">227±232</td>
                        <td align="left" rowspan="1" colspan="1">−39±233</td>
                        <td align="left" rowspan="1" colspan="1">−20±189</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.016</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">296±289</td>
                        <td align="left" rowspan="1" colspan="1">373±330</td>
                        <td align="left" rowspan="1" colspan="1">620±450</td>
                        <td align="left" rowspan="1" colspan="1">326±400<xref rid="jah38945-note-0021" ref-type="table-fn">†</xref>, <xref rid="jah38945-note-0022" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">213±381<xref rid="jah38945-note-0023" ref-type="table-fn">§</xref>, <xref rid="jah38945-note-0024" ref-type="table-fn">‖</xref>
</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">238±241</td>
                        <td align="left" rowspan="1" colspan="1">308±328</td>
                        <td align="left" rowspan="1" colspan="1">497±485</td>
                        <td align="left" rowspan="1" colspan="1">221±343<xref rid="jah38945-note-0022" ref-type="table-fn">‡</xref>, <xref rid="jah38945-note-0025" ref-type="table-fn">¶</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">117±329</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">High‐sensitivity C‐reactive protein, mg/L</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">7.5±6.5</td>
                        <td align="left" rowspan="1" colspan="1">7.1±6.9</td>
                        <td align="left" rowspan="1" colspan="1">4.8±4.8</td>
                        <td align="left" rowspan="1" colspan="1">−2.7±7.6<xref rid="jah38945-note-0025" ref-type="table-fn">¶</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">−2.0±7.8<xref rid="jah38945-note-0025" ref-type="table-fn">¶</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">5.0±4.0</td>
                        <td align="left" rowspan="1" colspan="1">3.6±2.5</td>
                        <td align="left" rowspan="1" colspan="1">2.5±1.2</td>
                        <td align="left" rowspan="1" colspan="1">−2.3±3.1</td>
                        <td align="left" rowspan="1" colspan="1">−1.1±2.3</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">4.2±4.7</td>
                        <td align="left" rowspan="1" colspan="1">3.1±3.0</td>
                        <td align="left" rowspan="1" colspan="1">2.9±1.9</td>
                        <td align="left" rowspan="1" colspan="1">−0.3±2.4</td>
                        <td align="left" rowspan="1" colspan="1">−0.4±2.4</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" colspan="8" rowspan="1">VEGF‐A, pg/L</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Control</td>
                        <td align="left" rowspan="1" colspan="1">35±33</td>
                        <td align="left" rowspan="1" colspan="1">42±47</td>
                        <td align="left" rowspan="1" colspan="1">51±61</td>
                        <td align="left" rowspan="1" colspan="1">21±55</td>
                        <td align="left" rowspan="1" colspan="1">9±43</td>
                        <td align="left" rowspan="1" colspan="1">0.956</td>
                        <td align="left" rowspan="1" colspan="1">0.464</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SET/HEP</td>
                        <td align="left" rowspan="1" colspan="1">59±89</td>
                        <td align="left" rowspan="1" colspan="1">77±107</td>
                        <td align="left" rowspan="1" colspan="1">106±131</td>
                        <td align="left" rowspan="1" colspan="1">42±61<xref rid="jah38945-note-0023" ref-type="table-fn">§</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">25±53</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HEP</td>
                        <td align="left" rowspan="1" colspan="1">57±57</td>
                        <td align="left" rowspan="1" colspan="1">68±63</td>
                        <td align="left" rowspan="1" colspan="1">121±70</td>
                        <td align="left" rowspan="1" colspan="1">45±53<xref rid="jah38945-note-0025" ref-type="table-fn">¶</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">47±59<xref rid="jah38945-note-0025" ref-type="table-fn">¶</xref>
</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38945-ntgp-0006">
                    <fn id="jah38945-note-0019">
                      <p>Data are presented as mean±SD. Calf StO<sub>2</sub> indicates calf oxygen saturation; HEP, home exercise program; SET, supervised exercise therapy; and VEGF‐A, vascular endothelial growth factor‐A.</p>
                    </fn>
                    <fn id="jah38945-note-0020">
                      <label>*</label>
                      <p>The models consider the variables of baseline outcome measures, group, visit time, and interaction between group and visit time. The <italic toggle="yes">P</italic>‐values are from Type III F test sums of squares and were adjusted using the Bonferroni correction method.</p>
                    </fn>
                    <fn id="jah38945-note-0021">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.001.</p>
                    </fn>
                    <fn id="jah38945-note-0022">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.01.</p>
                    </fn>
                    <fn id="jah38945-note-0023">
                      <label>
                        <sup>§</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.01.</p>
                    </fn>
                    <fn id="jah38945-note-0024">
                      <label>
                        <sup>‖</sup>
                      </label>
                      <p>Change is different from change of control group <italic toggle="yes">P</italic>&lt;0.05.</p>
                    </fn>
                    <fn id="jah38945-note-0025">
                      <label>
                        <sup>¶</sup>
                      </label>
                      <p>Change within group <italic toggle="yes">P</italic>&lt;0.05.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="jah38945-fig-0002">
                  <label>Figure 2</label>
                  <caption>
                    <title>Scatterplot and correlation between the changes in exercise time to minimum calf muscle oxygen saturation (StO<sub>2</sub>) with the changes in peak walking time.</title>
                    <p>HEP group shown as circles, and SET/HEP group shown as triangles. HEP indicates home exercise program, and SET/HEP indicates supervised exercise therapy that transitioned to a home exercise program.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e029755-g002" position="anchor" id="jats-graphic-3"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jah38945-sec-0033">
              <title>Discussion</title>
              <p>There are several novel findings in this long‐term randomized controlled trial focused on home exercise. Thirty‐eight out of 105 participants (36%) who completed the 3‐month HEP and SET exercise interventions agreed to participate in the long‐term HEP phase of the study. In these 38 participants, there was low attrition and high adherence to long‐term HEP. Secondly, both long‐term HEP and SET/HEP were efficacious in improving the primary outcome measures of PWT and exercise time to minimum calf muscle StO<sub>2</sub>, as well as secondary outcomes of COT, 6‐minute walk distance, and the number of steps taken and time spent in moderate intensity daily activity. Finally, the change in exercise time to minimum calf muscle StO<sub>2</sub> was correlated with the change in PWT with long‐term exercise.</p>
              <sec id="jah38945-sec-0034">
                <title>Exercise Adherence and Attrition</title>
                <p>Participants who agreed to continue in the optional long‐term phase of the study had high adherence during the short‐term HEP and SET programs, with both exceeding 90% of the prescribed 36 sessions. During the subsequent 15‐month long‐term phase, the participants who continued in the HEP completed an average of 2.5 exercise sessions per week, whereas the participants who transitioned from the SET program to HEP completed an average of &gt;3 exercise sessions per week. Although 4 other studies have examined HEP for 9<xref rid="jah38945-bib-0033" ref-type="bibr"><sup>33</sup></xref> to 12<xref rid="jah38945-bib-0034" ref-type="bibr"><sup>34</sup></xref>, <xref rid="jah38945-bib-0035" ref-type="bibr"><sup>35</sup></xref>, <xref rid="jah38945-bib-0036" ref-type="bibr"><sup>36</sup></xref> months, only 2 measured the exercise frequency, and found that participants completed an average of 3.5 weekly exercise sessions for 9 months,<xref rid="jah38945-bib-0033" ref-type="bibr"><sup>33</sup></xref> and 2.8 and 3.5 weekly exercise sessions for high‐ and low‐intensity groups for 12 months, respectively.<xref rid="jah38945-bib-0034" ref-type="bibr"><sup>34</sup></xref> The current study supports this observation, and extends the finding by showing that exercise adherence remains high at month 18 of HEP. Furthermore, there was low attrition with long‐term HEP, because only 4 of 38 participants in both exercise groups did not complete the program.</p>
              </sec>
              <sec id="jah38945-sec-0035">
                <title>Exercise Performance</title>
                <p>A major finding was that PWT and COT were increased from month 3 to month 18 during the long‐term HEP phase of this study. This was evident in both exercise groups, indicating that improvements in PWT and COT occurred regardless of whether participants initially performed short‐term HEP and then continued HEP for an additional 15 months, or whether they performed short‐term SET and then transitioned to long‐term HEP. These improvements in PWT and COT following long‐term HEP supports the efficacy of short‐term HEP in our previous studies<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> and those of other HEP interventions that used activity monitoring,<xref rid="jah38945-bib-0035" ref-type="bibr"><sup>35</sup></xref>, <xref rid="jah38945-bib-0036" ref-type="bibr"><sup>36</sup></xref>, <xref rid="jah38945-bib-0037" ref-type="bibr"><sup>37</sup></xref>, <xref rid="jah38945-bib-0038" ref-type="bibr"><sup>38</sup></xref>, <xref rid="jah38945-bib-0039" ref-type="bibr"><sup>39</sup></xref> or cognitive behavioral therapy.<xref rid="jah38945-bib-0040" ref-type="bibr"><sup>40</sup></xref>, <xref rid="jah38945-bib-0041" ref-type="bibr"><sup>41</sup></xref> Furthermore, the current study extends these observations by demonstrating that not only are improvements in PWT and COT maintained with long‐term HEP, but that additional gains beyond short‐term changes are possible as well. It is important to recognize that the increases in COT during the long‐term phase in both exercise groups between month 3 and month 18 were clinically important as well as statistically significant, because they exceeded the anchor‐based large minimal clinically important difference (MCID) of 101 seconds.<xref rid="jah38945-bib-0021" ref-type="bibr"><sup>21</sup></xref> The accompanying long‐term increases in PWT were also clinically important, because they exceeded the anchor‐based moderate MCID of 141 seconds, and they approached the large MCID threshold of 241 seconds.<xref rid="jah38945-bib-0021" ref-type="bibr"><sup>21</sup></xref>
</p>
                <p>A second key result related to exercise performance following long‐term HEP was that the pattern of change in 6‐minute walk distance was similar to the changes observed with PWT and COT. The 6‐minute walk distance increased during the long‐term phase from month 3 to month 18 and accounted for most of the change from baseline. This finding was evident in both exercise groups, indicating that improvements in 6‐minute walk distance occurred with long‐term HEP after a preceding 3‐month exercise intervention of either HEP or SET. The improvements in 6‐minute walk distance following long‐term HEP supports the efficacy of most shorter‐term HEP interventions<xref rid="jah38945-bib-0017" ref-type="bibr"><sup>17</sup></xref> but not all.<xref rid="jah38945-bib-0033" ref-type="bibr"><sup>33</sup></xref> Specifically, our results support a recent meta‐analysis that found 6‐minute walk distance increased in participants with PAD by an average of 0.28 standard deviations following structured HEPs compared with control groups. In a recent trial that found no change in 6‐minute walk distance following a 9‐month HEP, a likely explanation was that periodic onsite visits with research staff were not included throughout the HEP. In contrast, the current study required participants to visit the research center and meet with staff every 3 months. The 6‐minute walk distance increased by &gt;40 meters during the long‐term exercise phase in the exercise groups, which was clinically important, because this exceeded the anchor‐based large MCID of 34 meters.<xref rid="jah38945-bib-0021" ref-type="bibr"><sup>21</sup></xref>
</p>
              </sec>
              <sec id="jah38945-sec-0036">
                <title>Daily Ambulatory Activity</title>
                <p>The steps taken and time spent in moderate intensity daily walking activity increased in both exercise groups from baseline to month 18. The increases in daily steps and daily time spent in moderate intensity activity occurred during the short‐term phase of the HEP and SET/HEP programs, and they were maintained during the long‐term phase of the study. Our data indicate that participants with PAD who complete a short‐term HEP or SET program increase their daily walking at moderate intensity, and this was maintained during long‐term exercise. It is important to note that the total daily steps and the total daily activity time were not changed with either the HEP or SET/HEP interventions, which supports previous randomized controlled trials by us<xref rid="jah38945-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> and others.<xref rid="jah38945-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="jah38945-bib-0037" ref-type="bibr"><sup>37</sup></xref>, <xref rid="jah38945-bib-0039" ref-type="bibr"><sup>39</sup></xref> These observations indicate that the daily steps and time spent in moderate intensity are more responsive to exercise interventions than total daily steps and time spent in activity, and therefore may be the key outcome measures to obtain in future trials.</p>
                <p>The clinical importance of these daily activity findings is that after 3 months and 18 months of exercise intervention, both exercise groups on average met the physical activity time‐intensity guidelines of accumulating &gt;150 minutes of moderate intensity physical activity in a week (&gt;22 min/d).<xref rid="jah38945-bib-0042" ref-type="bibr"><sup>42</sup></xref> We previously estimated that &gt;1660 daily steps taken at moderate cadence was an optimal threshold for meeting the physical activity time‐intensity guidelines,<xref rid="jah38945-bib-0043" ref-type="bibr"><sup>43</sup></xref> and both exercise groups far exceeded this clinical cut point after 3 months and 18 months of exercise. Thus, participants not only improve their walking ability with a short‐term and long‐term exercise program, but they also may experience several cardiovascular and overall health benefits associated with meeting the physical activity time‐intensity guidelines.<xref rid="jah38945-bib-0043" ref-type="bibr"><sup>43</sup></xref> Finally, the increases from baseline in daily time spent in moderate intensity activity following exercise intervention were clinically important, because they exceeded the anchor‐based large MCID of 11 minu/d.<xref rid="jah38945-bib-0044" ref-type="bibr"><sup>44</sup></xref>
</p>
              </sec>
              <sec id="jah38945-sec-0037">
                <title>Vascular Function</title>
                <p>The main finding related to vascular function was that the exercise time to minimum calf StO<sub>2</sub> increased from baseline to month 18 in both exercise groups, and that there was an increase during the long‐term HEP phase of this study. This indicates that an improvement in the microcirculation of the calf muscle occurred following exercise intervention, because it took longer to desaturate to the minimum calf StO<sub>2</sub> value during the treadmill walking test. The improvement in exercise time to minimum calf StO<sub>2</sub> was achieved in participants in both long‐term exercise groups. The increased exercise time to minimum calf StO<sub>2</sub> following long‐term HEP supports the efficacy of our previous short‐term HEP intervention,<xref rid="jah38945-bib-0016" ref-type="bibr"><sup>16</sup></xref> and extends these observations by demonstrating that additional improvements in the microcirculation of the calf muscle occur beyond the short‐term changes. Furthermore, the finding that the changes in exercise time to minimum calf StO<sub>2</sub> were correlated with changes in PWT following long‐term exercise suggests that improvements in local oxygen saturation of the calf during exercise partially explains the increase in PWT. The clinical significance of these observations is that improvements in the microcirculation of the calf muscle during exercise is a possible physiologic mechanism for the improvement in PWT.</p>
              </sec>
              <sec id="jah38945-sec-0038">
                <title>Limitations</title>
                <p>Although this trial supports the long‐term efficacy of HEP for PAD participants, several limitations exist. One limitation is that participants volunteered to participate in this study. Thus, a self‐selection bias may exist because they may represent those who had greater interest in participating, better access to transportation to the research center, and better health than PAD participants who did not volunteer. A second limitation is that the participants who completed the 3‐month short‐term study who agreed to continue in the long‐term phase of the study represent the most motivated participants. However, in post hoc analyses, the participants who continued in the long‐term phase of the study were not different either at baseline or at 3‐month follow‐up on PWT, COT, 6‐minute walk distance, and Walking Impairment Questionnaire scores than those who only participated in the short‐term phase. Furthermore, no differences were found for the prevalence of comorbid conditions. Another limitation is that the results of this study are only generalizable to participants with symptomatic PAD, and may not be applicable to participants with less severe or more severe PAD. Another limitation is that although participants were randomized into 1 of the groups before intervention, it is possible that the motivation to participate in the trial was different among the groups. There is some attrition bias associated with the data, because 4 out of the 72 participants who agreed to participate in the long‐term phase of the study did not complete the month 18 evaluations. Additionally, as is true with exercise studies, blinding of the participants to the exercise interventions was not possible, leading to some performance bias in the data. Finally, other bias may exist in the study that cannot be accounted.</p>
              </sec>
            </sec>
            <sec id="jah38945-sec-0039">
              <title>Conclusions and Clinical Implications</title>
              <p>Long‐term HEP and SET/HEP were efficacious in improving PWT and exercise time to minimum calf muscle StO<sub>2</sub> in symptomatic participants with PAD, and these changes were correlated with each other. The clinical significance is that long‐term HEP and SET/HEP interventions that use activity monitoring were efficacious to improve both claudication and microvascular function of the calf muscle in symptomatic participants with PAD.</p>
            </sec>
            <sec id="jah38945-sec-0040">
              <title>Sources of Funding</title>
              <p>This work was supported by the National Institute on Aging (R01‐AG‐24296), Oklahoma Center for Advancement of Science and Technology (HR09‐035), American Heart Association (15GRNT23040034), and University of Oklahoma Health Sciences Center General Clinical Research Center (M01‐RR‐14467) from the National Center for Research Resources.</p>
            </sec>
            <sec id="jah38945-sec-0041">
              <title>Disclosures</title>
              <p>The authors do not have any disclosures.</p>
            </sec>
          </body>
          <back>
            <ref-list content-type="cited-references" id="jah38945-bibl-0001">
              <title>References</title>
              <ref id="jah38945-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0001"><string-name><surname>Song</surname><given-names>P</given-names></string-name>, <string-name><surname>Rudan</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FJI</given-names></string-name>, <string-name><surname>Rahimi</surname><given-names>K</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FGR</given-names></string-name>, <string-name><surname>Rudan</surname><given-names>I</given-names></string-name>. <article-title>Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis</article-title>. <source>Lancet Glob Health</source>. <year>2019</year>;<volume>7</volume>:<fpage>e1020</fpage>–<lpage>e1030</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(19)30255-4</pub-id>
<pub-id pub-id-type="pmid">31303293</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0002"><string-name><surname>Norgren</surname><given-names>L</given-names></string-name>, <string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>, <string-name><surname>Dormandy</surname><given-names>JA</given-names></string-name>, <string-name><surname>Nehler</surname><given-names>MR</given-names></string-name>, <string-name><surname>Harris</surname><given-names>KA</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FG</given-names></string-name>. <article-title>Inter‐society consensus for the management of peripheral arterial disease (TASC II)</article-title>. <source>J Vasc Surg</source>. <year>2007</year>;<volume>45</volume>:<fpage>S5</fpage>–<lpage>S67</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2006.12.037</pub-id>
<pub-id pub-id-type="pmid">17223489</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0003"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Skinner</surname><given-names>JS</given-names></string-name>, <string-name><surname>Cantwell</surname><given-names>BW</given-names></string-name>, <string-name><surname>Smith</surname><given-names>LK</given-names></string-name>. <article-title>Progressive vs single‐stage treadmill tests for evaluation of claudication</article-title>. <source>Med Sci Sports Exerc</source>. <year>1991</year>;<volume>23</volume>:<fpage>402</fpage>–<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1249/00005768-199104000-00003</pub-id>
<pub-id pub-id-type="pmid">2056896</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0004"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Greenland</surname><given-names>P</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Dolan</surname><given-names>NC</given-names></string-name>, <string-name><surname>Chan</surname><given-names>C</given-names></string-name>, <string-name><surname>Celic</surname><given-names>L</given-names></string-name>, <string-name><surname>Pearce</surname><given-names>WH</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>JR</given-names></string-name>, et al. <article-title>Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment</article-title>. <source>JAMA</source>. <year>2001</year>;<volume>286</volume>:<fpage>1599</fpage>–<lpage>1606</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.286.13.1599</pub-id>
<pub-id pub-id-type="pmid">11585483</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0005"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Scott</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Afaq</surname><given-names>A</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>. <article-title>Patterns of ambulatory activity in subjects with and without intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2007</year>;<volume>46</volume>:<fpage>1208</fpage>–<lpage>1214</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2007.07.038</pub-id>
<pub-id pub-id-type="pmid">17919876</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0006"><string-name><surname>Regensteiner</surname><given-names>JG</given-names></string-name>, <string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>, <string-name><surname>Coll</surname><given-names>JR</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Treat‐Jacobson</surname><given-names>D</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Hirsch</surname><given-names>AT</given-names></string-name>. <article-title>The impact of peripheral arterial disease on health‐related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program</article-title>. <source>Vasc Med</source>. <year>2008</year>;<volume>13</volume>:<fpage>15</fpage>–<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358863X07084911</pub-id>
<pub-id pub-id-type="pmid">18372434</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0007"><string-name><surname>Gerhard‐Herman</surname><given-names>MD</given-names></string-name>, <string-name><surname>Gornik</surname><given-names>HL</given-names></string-name>, <string-name><surname>Barrett</surname><given-names>C</given-names></string-name>, <string-name><surname>Barshes</surname><given-names>NR</given-names></string-name>, <string-name><surname>Corriere</surname><given-names>MA</given-names></string-name>, <string-name><surname>Drachman</surname><given-names>DE</given-names></string-name>, <string-name><surname>Fleisher</surname><given-names>LA</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FG</given-names></string-name>, <string-name><surname>Hamburg</surname><given-names>NM</given-names></string-name>, <string-name><surname>Kinlay</surname><given-names>S</given-names></string-name>, et al. <article-title>2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</article-title>. <source>Circulation</source>. <year>2017</year>;<volume>135</volume>:<fpage>e686</fpage>–<lpage>e725</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000000470</pub-id>
<pub-id pub-id-type="pmid">27840332</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0008"><string-name><surname>Saxon</surname><given-names>JT</given-names></string-name>, <string-name><surname>Safley</surname><given-names>DM</given-names></string-name>, <string-name><surname>Mena‐Hurtado</surname><given-names>C</given-names></string-name>, <string-name><surname>Heyligers</surname><given-names>J</given-names></string-name>, <string-name><surname>Fitridge</surname><given-names>R</given-names></string-name>, <string-name><surname>Shishehbor</surname><given-names>M</given-names></string-name>, <string-name><surname>Spertus</surname><given-names>JA</given-names></string-name>, <string-name><surname>Gosch</surname><given-names>K</given-names></string-name>, <string-name><surname>Patel</surname><given-names>MR</given-names></string-name>, <string-name><surname>Smolderen</surname><given-names>KG</given-names></string-name>. <article-title>Adherence to guideline‐recommended therapy‐including supervised exercise therapy referral‐across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry</article-title>. <source>J Am Heart Assoc</source>. <year>2020</year>;<volume>9</volume>:<elocation-id>e012541</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.119.012541</pub-id><pub-id pub-id-type="pmid">31973609</pub-id></mixed-citation>
              </ref>
              <ref id="jah38945-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0009"><string-name><surname>Harwood</surname><given-names>AE</given-names></string-name>, <string-name><surname>Hitchman</surname><given-names>LH</given-names></string-name>, <string-name><surname>Ingle</surname><given-names>L</given-names></string-name>, <string-name><surname>Doherty</surname><given-names>P</given-names></string-name>, <string-name><surname>Chetter</surname><given-names>IC</given-names></string-name>. <article-title>Preferred exercise modalities in patients with intermittent claudication</article-title>. <source>J Vasc Nurs</source>. <year>2018</year>;<volume>36</volume>:<fpage>81</fpage>–<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvn.2017.12.002</pub-id>
<pub-id pub-id-type="pmid">29747787</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0010"><string-name><surname>Dua</surname><given-names>A</given-names></string-name>, <string-name><surname>Gologorsky</surname><given-names>R</given-names></string-name>, <string-name><surname>Savage</surname><given-names>D</given-names></string-name>, <string-name><surname>Rens</surname><given-names>N</given-names></string-name>, <string-name><surname>Gandhi</surname><given-names>N</given-names></string-name>, <string-name><surname>Brooke</surname><given-names>B</given-names></string-name>, <string-name><surname>Corriere</surname><given-names>M</given-names></string-name>, <string-name><surname>Jackson</surname><given-names>E</given-names></string-name>, <string-name><surname>Aalami</surname><given-names>O</given-names></string-name>. <article-title>National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2020</year>;<volume>71</volume>:<fpage>1702</fpage>–<lpage>1707</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2019.08.238</pub-id>
<pub-id pub-id-type="pmid">31699514</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0011"><string-name><surname>Harwood</surname><given-names>AE</given-names></string-name>, <string-name><surname>Smith</surname><given-names>GE</given-names></string-name>, <string-name><surname>Cayton</surname><given-names>T</given-names></string-name>, <string-name><surname>Broadbent</surname><given-names>E</given-names></string-name>, <string-name><surname>Chetter</surname><given-names>IC</given-names></string-name>. <article-title>A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication</article-title>. <source>Ann Vasc Surg</source>. <year>2016</year>;<volume>34</volume>:<fpage>280</fpage>–<lpage>289</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.avsg.2016.02.009</pub-id>
<pub-id pub-id-type="pmid">27126713</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0012"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>. <article-title>Reducing disability in peripheral artery disease: the role of revascularization and supervised exercise therapy</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2019</year>;<volume>12</volume>:<fpage>1137</fpage>–<lpage>1139</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcin.2019.03.017</pub-id>
<pub-id pub-id-type="pmid">31153845</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0013"><string-name><surname>Treat‐Jacobson</surname><given-names>D</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Bronas</surname><given-names>UG</given-names></string-name>, <string-name><surname>Campia</surname><given-names>U</given-names></string-name>, <string-name><surname>Collins</surname><given-names>TC</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>, <string-name><surname>Regensteiner</surname><given-names>JG</given-names></string-name>, <string-name><surname>Rich</surname><given-names>K</given-names></string-name>, et al. <article-title>Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association</article-title>. <source>Circulation</source>. <year>2019</year>;<volume>139</volume>:<fpage>e10</fpage>–<lpage>e33</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000000623</pub-id>
<pub-id pub-id-type="pmid">30586765</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0014"><string-name><surname>Treat‐Jacobson</surname><given-names>D</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Beckman</surname><given-names>JA</given-names></string-name>, <string-name><surname>Burt</surname><given-names>MA</given-names></string-name>, <string-name><surname>Creager</surname><given-names>MA</given-names></string-name>, <string-name><surname>Ehrman</surname><given-names>JK</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Mays</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Regensteiner</surname><given-names>JG</given-names></string-name>, <string-name><surname>Salisbury</surname><given-names>DL</given-names></string-name>, et al. <article-title>Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association</article-title>. <source>Circulation</source>. <year>2019</year>;<volume>140</volume>:<fpage>e700</fpage>–<lpage>e710</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000000727</pub-id>
<pub-id pub-id-type="pmid">31446770</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0015"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Parker</surname><given-names>DE</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Scott</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>. <article-title>Efficacy of quantified home‐based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>123</volume>:<fpage>491</fpage>–<lpage>498</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.963066</pub-id>
<pub-id pub-id-type="pmid">21262997</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0016"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Parker</surname><given-names>DE</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>. <article-title>Step‐monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial</article-title>. <source>J Am Heart Assoc</source>. <year>2014</year>;<volume>3</volume>:<elocation-id>e001107</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.114.001107</pub-id><pub-id pub-id-type="pmid">25237048</pub-id></mixed-citation>
              </ref>
              <ref id="jah38945-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0017"><string-name><surname>Golledge</surname><given-names>J</given-names></string-name>, <string-name><surname>Singh</surname><given-names>TP</given-names></string-name>, <string-name><surname>Alahakoon</surname><given-names>C</given-names></string-name>, <string-name><surname>Pinchbeck</surname><given-names>J</given-names></string-name>, <string-name><surname>Yip</surname><given-names>L</given-names></string-name>, <string-name><surname>Moxon</surname><given-names>JV</given-names></string-name>, <string-name><surname>Morris</surname><given-names>DR</given-names></string-name>. <article-title>Meta‐analysis of clinical trials examining the benefit of structured home exercise in patients with peripheral artery disease</article-title>. <source>Br J Surg</source>. <year>2019</year>;<volume>106</volume>:<fpage>319</fpage>–<lpage>331</lpage>. doi: <pub-id pub-id-type="doi">10.1002/bjs.11101</pub-id>
<pub-id pub-id-type="pmid">30791089</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0018"><string-name><surname>Pymer</surname><given-names>S</given-names></string-name>, <string-name><surname>Ibeggazene</surname><given-names>S</given-names></string-name>, <string-name><surname>Palmer</surname><given-names>J</given-names></string-name>, <string-name><surname>Tew</surname><given-names>GA</given-names></string-name>, <string-name><surname>Ingle</surname><given-names>L</given-names></string-name>, <string-name><surname>Smith</surname><given-names>GE</given-names></string-name>, <string-name><surname>Chetter</surname><given-names>IC</given-names></string-name>, <string-name><surname>Harwood</surname><given-names>AE</given-names></string-name>. <article-title>An updated systematic review and meta‐analysis of home‐based exercise programs for individuals with intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2021</year>;<volume>74</volume>:<fpage>2076</fpage>–<lpage>2085.e20</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2021.03.063</pub-id>
<pub-id pub-id-type="pmid">34087396</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0019"><string-name><surname>Chan</surname><given-names>C</given-names></string-name>, <string-name><surname>Sounderajah</surname><given-names>V</given-names></string-name>, <string-name><surname>Normahani</surname><given-names>P</given-names></string-name>, <string-name><surname>Acharya</surname><given-names>A</given-names></string-name>, <string-name><surname>Markar</surname><given-names>SR</given-names></string-name>, <string-name><surname>Darzi</surname><given-names>A</given-names></string-name>, <string-name><surname>Bicknell</surname><given-names>C</given-names></string-name>, <string-name><surname>Riga</surname><given-names>C</given-names></string-name>. <article-title>Wearable activity monitors in home based exercise therapy for patients with intermittent claudication: a systematic review</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2021</year>;<volume>61</volume>:<fpage>676</fpage>–<lpage>687</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejvs.2020.11.044</pub-id>
<pub-id pub-id-type="pmid">33451865</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0020"><string-name><surname>Gommans</surname><given-names>LN</given-names></string-name>, <string-name><surname>Saarloos</surname><given-names>R</given-names></string-name>, <string-name><surname>Scheltinga</surname><given-names>MR</given-names></string-name>, <string-name><surname>Houterman</surname><given-names>S</given-names></string-name>, <string-name><surname>de Bie</surname><given-names>RA</given-names></string-name>, <string-name><surname>Fokkenrood</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Teijink</surname><given-names>JA</given-names></string-name>. <article-title>Editor's choice–the effect of supervision on walking distance in patients with intermittent claudication: a meta‐analysis</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2014</year>;<volume>48</volume>:<fpage>169</fpage>–<lpage>184</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejvs.2014.04.019</pub-id>
<pub-id pub-id-type="pmid">24928167</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0021"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M</given-names></string-name>. <article-title>Minimal clinically important differences in treadmill, 6‐minute walk, and patient‐based outcomes following supervised and home‐based exercise in peripheral artery disease</article-title>. <source>Vasc Med</source>. <year>2018</year>;<volume>23</volume>:<fpage>349</fpage>–<lpage>357</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358863X18762599</pub-id>
<pub-id pub-id-type="pmid">29671381</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0022"><string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>, <string-name><surname>Marshall</surname><given-names>JA</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>J</given-names></string-name>, <string-name><surname>Sandoval</surname><given-names>R</given-names></string-name>, <string-name><surname>Hildebrandt</surname><given-names>W</given-names></string-name>, <string-name><surname>Kahn</surname><given-names>LR</given-names></string-name>, <string-name><surname>Hamman</surname><given-names>RF</given-names></string-name>. <article-title>Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study</article-title>. <source>J Clin Epidemiol</source>. <year>1990</year>;<volume>43</volume>:<fpage>597</fpage>–<lpage>606</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0895-4356(90)90164-K</pub-id>
<pub-id pub-id-type="pmid">2189949</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0023"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Flinn</surname><given-names>WR</given-names></string-name>, <string-name><surname>Katzel</surname><given-names>LI</given-names></string-name>. <article-title>The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2005</year>;<volume>42</volume>:<fpage>702</fpage>–<lpage>709</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2005.05.049</pub-id>
<pub-id pub-id-type="pmid">16242558</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0024"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Parker</surname><given-names>DE</given-names></string-name>, <string-name><surname>Webb</surname><given-names>N</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Scott</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>. <article-title>Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2008</year>;<volume>48</volume>:<fpage>644</fpage>–<lpage>649</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2008.04.005</pub-id>
<pub-id pub-id-type="pmid">18572363</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0025"><string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>. <article-title>The clinical utility of a six‐minute walk test in peripheral arterial occlusive disease patients</article-title>. <source>J Am Geriatr Soc</source>. <year>1998</year>;<volume>46</volume>:<fpage>706</fpage>–<lpage>711</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.1998.tb03804.x</pub-id>
<pub-id pub-id-type="pmid">9625185</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0026"><string-name><surname>Regensteiner</surname><given-names>JG</given-names></string-name>, <string-name><surname>Steiner</surname><given-names>JF</given-names></string-name>, <string-name><surname>Panzer</surname><given-names>RL</given-names></string-name>, <string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>. <article-title>Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease</article-title>. <source>J Vasc Med Biol</source>. <year>1990</year>;<volume>2</volume>:<fpage>142</fpage>–<lpage>152</lpage>.</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0027"><string-name><surname>Ware</surname><given-names>JE</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Sherbourne</surname><given-names>CD</given-names></string-name>. <article-title>The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection</article-title>. <source>Med Care</source>. <year>1992</year>;<volume>30</volume>:<fpage>473</fpage>–<lpage>483</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00005650-199206000-00002</pub-id>
<pub-id pub-id-type="pmid">1593914</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0028"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Parker</surname><given-names>DE</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Khurana</surname><given-names>A</given-names></string-name>, <string-name><surname>Ritti‐Dias</surname><given-names>RM</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>. <article-title>Gender differences in daily ambulatory activity patterns in patients with intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2010</year>;<volume>52</volume>:<fpage>1204</fpage>–<lpage>1210</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2010.05.115</pub-id>
<pub-id pub-id-type="pmid">20692790</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0029"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Parker</surname><given-names>DE</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>, <string-name><surname>Teague</surname><given-names>AM</given-names></string-name>, <string-name><surname>Casanegra</surname><given-names>AI</given-names></string-name>. <article-title>Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication</article-title>. <source>Angiology</source>. <year>2013</year>;<volume>65</volume>:<fpage>491</fpage>–<lpage>496</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0003319713489769</pub-id>
<pub-id pub-id-type="pmid">23695338</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0030"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>YD</given-names></string-name>, <string-name><surname>Silva‐Palacios</surname><given-names>F</given-names></string-name>, <string-name><surname>Ungvari</surname><given-names>Z</given-names></string-name>, <string-name><surname>Csiszar</surname><given-names>A</given-names></string-name>, <string-name><surname>Sonntag</surname><given-names>WE</given-names></string-name>. <article-title>Association between daily walking and antioxidant capacity in patients with symptomatic peripheral artery disease</article-title>. <source>J Vasc Surg</source>. <year>2017</year>;<volume>65</volume>:<fpage>1762</fpage>–<lpage>1768</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2016.12.108</pub-id>
<pub-id pub-id-type="pmid">28259579</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0031"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Scott</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>SM</given-names></string-name>, <string-name><surname>Afaq</surname><given-names>A</given-names></string-name>, <string-name><surname>Nael</surname><given-names>R</given-names></string-name>. <article-title>Association between daily ambulatory activity patterns and exercise performance in patients with intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2008</year>;<volume>48</volume>:<fpage>1238</fpage>–<lpage>1244</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2008.06.062</pub-id>
<pub-id pub-id-type="pmid">18771878</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0032"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Casanegra</surname><given-names>AI</given-names></string-name>, <string-name><surname>Silva‐Palacios</surname><given-names>F</given-names></string-name>, <string-name><surname>Ungvari</surname><given-names>Z</given-names></string-name>, <string-name><surname>Csiszar</surname><given-names>A</given-names></string-name>. <article-title>Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease</article-title>. <source>Age</source>. <year>2016</year>;<volume>38</volume>:<fpage>64</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11357-016-9925-y</pub-id><pub-id pub-id-type="pmid">27273077</pub-id></mixed-citation>
              </ref>
              <ref id="jah38945-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0033"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Berger</surname><given-names>JS</given-names></string-name>, <string-name><surname>Treat‐Jacobson</surname><given-names>D</given-names></string-name>, <string-name><surname>Conte</surname><given-names>MS</given-names></string-name>, <string-name><surname>Creager</surname><given-names>MA</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Gornik</surname><given-names>HL</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, et al. <article-title>Effect of a home‐based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial</article-title>. <source>JAMA</source>. <year>2018</year>;<volume>319</volume>:<fpage>1665</fpage>–<lpage>1676</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2018.3275</pub-id>
<pub-id pub-id-type="pmid">29710165</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0034"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Treat‐Jacobson</surname><given-names>D</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Lloyd‐Jones</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>L</given-names></string-name>, <string-name><surname>Polonsky</surname><given-names>T</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>MR</given-names></string-name>, <string-name><surname>Bazzano</surname><given-names>L</given-names></string-name>, et al. <article-title>Effect of low‐intensity vs high‐intensity home‐based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>325</volume>:<fpage>1266</fpage>–<lpage>1276</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2021.2536</pub-id>
<pub-id pub-id-type="pmid">33821898</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0035"><string-name><surname>Normahani</surname><given-names>P</given-names></string-name>, <string-name><surname>Kwasnicki</surname><given-names>R</given-names></string-name>, <string-name><surname>Bicknell</surname><given-names>C</given-names></string-name>, <string-name><surname>Allen</surname><given-names>L</given-names></string-name>, <string-name><surname>Jenkins</surname><given-names>MP</given-names></string-name>, <string-name><surname>Gibbs</surname><given-names>R</given-names></string-name>, <string-name><surname>Cheshire</surname><given-names>N</given-names></string-name>, <string-name><surname>Darzi</surname><given-names>A</given-names></string-name>, <string-name><surname>Riga</surname><given-names>C</given-names></string-name>. <article-title>Wearable sensor technology efficacy in peripheral vascular disease (wSTEP): a randomized controlled trial</article-title>. <source>Ann Surg</source>. <year>2018</year>;<volume>268</volume>:<fpage>1113</fpage>–<lpage>1118</lpage>. doi: <pub-id pub-id-type="doi">10.1097/SLA.0000000000002300</pub-id>
<pub-id pub-id-type="pmid">28498233</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0036"><string-name><surname>Nicolai</surname><given-names>SP</given-names></string-name>, <string-name><surname>Teijink</surname><given-names>JA</given-names></string-name>, <string-name><surname>Prins</surname><given-names>MH</given-names></string-name>; <collab collab-type="authors">Exercise Therapy in Peripheral Arterial Disease Study Group</collab>
. <article-title>Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2010</year>;<volume>52</volume>:<fpage>348</fpage>–<lpage>355</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2010.02.022</pub-id>
<pub-id pub-id-type="pmid">20478681</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0037"><string-name><surname>Duscha</surname><given-names>BD</given-names></string-name>, <string-name><surname>Piner</surname><given-names>LW</given-names></string-name>, <string-name><surname>Patel</surname><given-names>MP</given-names></string-name>, <string-name><surname>Crawford</surname><given-names>LE</given-names></string-name>, <string-name><surname>Jones</surname><given-names>WS</given-names></string-name>, <string-name><surname>Patel</surname><given-names>MR</given-names></string-name>, <string-name><surname>Kraus</surname><given-names>WE</given-names></string-name>. <article-title>Effects of a 12‐week mHealth program on functional capacity and physical activity in patients with peripheral artery disease</article-title>. <source>Am J Cardiol</source>. <year>2018</year>;<volume>122</volume>:<fpage>879</fpage>–<lpage>884</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amjcard.2018.05.018</pub-id>
<pub-id pub-id-type="pmid">30049464</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0038"><string-name><surname>Mays</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>, <string-name><surname>Casserly</surname><given-names>IP</given-names></string-name>, <string-name><surname>Rogers</surname><given-names>RK</given-names></string-name>, <string-name><surname>Main</surname><given-names>DS</given-names></string-name>, <string-name><surname>Kohrt</surname><given-names>WM</given-names></string-name>, <string-name><surname>Ho</surname><given-names>PM</given-names></string-name>, <string-name><surname>Regensteiner</surname><given-names>JG</given-names></string-name>. <article-title>Community‐based walking exercise for peripheral artery disease: an exploratory pilot study</article-title>. <source>Vasc Med</source>. <year>2015</year>;<volume>20</volume>:<fpage>339</fpage>–<lpage>347</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358863X15572725</pub-id>
<pub-id pub-id-type="pmid">25755148</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0039"><string-name><surname>Tew</surname><given-names>GA</given-names></string-name>, <string-name><surname>Humphreys</surname><given-names>L</given-names></string-name>, <string-name><surname>Crank</surname><given-names>H</given-names></string-name>, <string-name><surname>Hewitt</surname><given-names>C</given-names></string-name>, <string-name><surname>Nawaz</surname><given-names>S</given-names></string-name>, <string-name><surname>Al‐Jundi</surname><given-names>W</given-names></string-name>, <string-name><surname>Trender</surname><given-names>H</given-names></string-name>, <string-name><surname>Michaels</surname><given-names>J</given-names></string-name>, <string-name><surname>Gorely</surname><given-names>T</given-names></string-name>. <article-title>The development and pilot randomised controlled trial of a group education programme for promoting walking in people with intermittent claudication</article-title>. <source>Vasc Med</source>. <year>2015</year>;<volume>20</volume>:<fpage>348</fpage>–<lpage>357</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358863X15577857</pub-id>
<pub-id pub-id-type="pmid">25858012</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0040"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Domanchuk</surname><given-names>K</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Lloyd‐Jones</surname><given-names>D</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>M</given-names></string-name>, et al. <article-title>Home‐based walking exercise intervention in peripheral artery disease: a randomized clinical trial</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>310</volume>:<fpage>57</fpage>–<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2013.7231</pub-id>
<pub-id pub-id-type="pmid">23821089</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0041"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>L</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Domanchuk</surname><given-names>K</given-names></string-name>, <string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>M</given-names></string-name>, et al. <article-title>Home‐based walking exercise in peripheral artery disease: 12‐month follow‐up of the goals randomized trial</article-title>. <source>J Am Heart Assoc</source>. <year>2014</year>;<volume>3</volume>:<elocation-id>e000711</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.113.000711</pub-id>
<pub-id pub-id-type="pmid">24850615</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0042"><string-name><surname>Piercy</surname><given-names>KL</given-names></string-name>, <string-name><surname>Troiano</surname><given-names>RP</given-names></string-name>, <string-name><surname>Ballard</surname><given-names>RM</given-names></string-name>, <string-name><surname>Carlson</surname><given-names>SA</given-names></string-name>, <string-name><surname>Fulton</surname><given-names>JE</given-names></string-name>, <string-name><surname>Galuska</surname><given-names>DA</given-names></string-name>, <string-name><surname>George</surname><given-names>SM</given-names></string-name>, <string-name><surname>Olson</surname><given-names>RD</given-names></string-name>. <article-title>The physical activity guidelines for Americans</article-title>. <source>JAMA</source>. <year>2018</year>;<volume>320</volume>:<fpage>2020</fpage>–<lpage>2028</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2018.14854</pub-id>
<pub-id pub-id-type="pmid">30418471</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0043"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name><surname>Shen</surname><given-names>B</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name><surname>Pomilla</surname><given-names>WA</given-names></string-name>. <article-title>Association between meeting physical activity time‐intensity guidelines with ambulation, quality of life, and inflammation in claudication</article-title>. <source>J Cardiopulm Rehabil Prev</source>. <year>2022</year>;<volume>42</volume>:<fpage>E82</fpage>–<lpage>E89</lpage>. doi: <pub-id pub-id-type="doi">10.1097/HCR.0000000000000686</pub-id>
<pub-id pub-id-type="pmid">35385857</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38945-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jah38945-cit-0044"><string-name><surname>Gardner</surname><given-names>AW</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>PS</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name><surname>Shen</surname><given-names>B</given-names></string-name>. <article-title>Minimal clinically important differences in daily physical activity outcomes following supervised and home‐based exercise in peripheral artery disease</article-title>. <source>Vasc Med</source>. <year>2022</year>;<volume>27</volume>:<fpage>142</fpage>–<lpage>149</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358863X211072913</pub-id>
<pub-id pub-id-type="pmid">35164605</pub-id>
</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
